Share General Information
Momelotinib is a Janus Kinase inhibitor used to treat intermediate or high-risk myelofibrosis.
About the API
Molecular Formula
C23H22N6O2
Therapeutic category
Oncology
Systematic Name
N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide
Available formulations
Oral Solid
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
